先端巨大症/巨人症治療薬の世界市場機会分析...市場調査レポートについてご紹介

【英文タイトル】OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 14
1.2 List of Figures 16

2 Introduction 17
2.1 Catalyst 17
2.2 Upcoming Related Reports 18

3 Disease Overview 19
3.1 Etiology and Pathophysiology 20
3.1.1 Etiology 20
3.1.2 Pathophysiology 21
3.2 Symptoms 22
3.3 Prognosis 23
3.4 Quality of Life 23

4 Epidemiology 25
4.1 Disease Background 25
4.2 Risk Factors and Comorbidities 25
4.3 Global Trends 27
4.4 Forecast Methodology 28
4.4.1 Sources Used 29
4.4.2 Sources Not Used 34
4.4.3 Forecast Assumptions and Methods 36
4.5 Epidemiological Forecast for Acromegaly (2013-2023) 46
4.5.1 Diagnosed Prevalent Cases of Acromegaly 46
4.5.2 Age-Specific Diagnosed Prevalent Cases of Acromegaly 48
4.5.3 Sex-Specific Diagnosed Prevalent Cases of Acromegaly 49
4.5.4 Age-Standardized Diagnosed Prevalence of Acromegaly 51
4.6 Epidemiological Forecast for Gigantism (2013-2023) 52
4.6.1 Diagnosed Prevalent Cases of Gigantism 52
4.6.2 Age-Specific Diagnosed Prevalent Cases of Gigantism 54
4.6.3 Sex-Specific Diagnosed Prevalent Cases of Gigantism 55
4.6.4 Age-Standardized Diagnosed Prevalence of Gigantism 57
4.7 Epidemiological Forecast for Acromegaly and Gigantism with Macroadenomas, Microadenomas, and Cases Receiving Any Surgical Treatment (2013-2023) 58
4.7.1 Diagnosed Prevalent Cases of Acromegaly and Gigantism with Macroadenomas 58
4.7.2 Diagnosed Prevalent Cases of Acromegaly and Gigantism with Microadenomas 59
4.7.3 Diagnosed Prevalent Cases of Acromegaly and Gigantism Receiving Any Surgical Treatment 60
4.8 Discussion 61
4.8.1 Epidemiological Forecast Insight 61
4.8.2 Limitations of the Analysis 62
4.8.3 Strengths of the Analysis 63

5 Current Treatment Options 64
5.1 Disease Diagnosis 64
5.2 Criteria for Cure and Treatment Goals 65
5.3 Treatment Overview 65
5.4 Clinical Practice 70
5.5 Product Profiles – Somatostatin Analogs 71
5.5.1 Sandostatin SC and Sandostatin LAR Depot (Octreotide Acetate) 71
5.5.2 Somatuline LA and Somatuline Depot (Lanreotide Acetate) 77
5.6 Product Profile – Growth Hormone Receptor Antagonists 81
5.6.1 Somavert (Pegvisomant) 81
5.7 Product Profiles – Dopamine Agonists 87
5.7.1 Cabergoline and Bromocriptine (Widely Genericized) 87

6 Unmet Needs Assessment and Opportunity Analysis 89
6.1 Overview 89
6.2 Improved Efficacy and Safety 90
6.2.1 Unmet Needs 90
6.2.2 Gap Analysis 91
6.2.3 Opportunity 92
6.3 Treatment of Comorbidities 92
6.3.1 Unmet Needs 92
6.3.2 Gap Analysis 93
6.3.3 Opportunity 94
6.4 Physician and Patient Education 94
6.4.1 Unmet Needs 94
6.4.2 Gap Analysis 95
6.4.3 Opportunity Analysis 96
6.5 Improvement in Assay Standardization 96
6.5.1 Unmet Needs 96
6.5.2 Gap Analysis 97
6.5.3 Opportunity Analysis 98

7 R&D Strategies 99
7.1 Overview 99
7.1.1 Targeting Refractory Patients by Improving Existing Drug Classes 99
7.1.2 Novel Drug Delivery Strategies 100
7.1.3 Reformulation Strategies to Reduce Dosing Frequency 101
7.1.4 Licensing and Acquisitions 102
7.2 Clinical Trial Design 102
7.2.1 Current Clinical Trial Design 103
7.2.2 Future Clinical Trial Design 105

8 Pipeline Assessment 106
8.1 Overview 106
8.2 Promising Drugs in Clinical Development 107
8.2.1 Signifor LAR (Pasireotide) 108
8.2.2 Oral Octreotide (Octreotide Acetate) 112
8.2.3 ATL1103 117
8.3 Other Phase III Trials 120
8.4 Innovative Early-Stage Approaches 121

9 Pipeline Valuation Analysis 124
9.1 Clinical Benchmark of Key Pipeline Drugs 124
9.2 Commercial Benchmark of Key Pipeline Drugs 125
9.3 Competitive Assessment 126
9.4 Top-Line Five-Year Forecast 129
9.4.1 US 133
9.4.2 5EU 134

10 Appendix 136
10.1 Bibliography 136
10.2 Abbreviations 146
10.3 Methodology 149
10.4 Forecasting Methodology 149
10.4.1 Diagnosed Acromegaly and Gigantism Patients 149
10.4.2 Percent of Drug-Treated Patients 150
10.4.3 Drugs Included in Each Therapeutic Class 150
10.4.4 Launch and Patent Expiry Dates 150
10.4.5 General Pricing Assumptions 151
10.4.6 Individual Drug Assumptions 152
10.4.7 Generic Erosion 154
10.4.8 Pricing of Pipeline Agents 155
10.5 Physicians and Specialists Included in this Study 156
10.6 About the Authors 157
10.6.1 Analyst 157
10.6.2 Epidemiologist 157
10.6.3 Therapy Director – CVMD 158
10.6.4 Global Head of Healthcare 158
10.7 About GlobalData 159
10.8 Disclaimer 159


【レポート販売概要】

■ タイトル:先端巨大症/巨人症治療薬の世界市場機会分析
■ 英文:OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018
■ 発行日:2014年12月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC028POA
■ 調査対象地域:グローバル
  • Hoya Corporation:市場シェア分析
    Hoya Corporation Market Share Analysis Summary GlobalData’s new report, “Hoya Corporation Market Share Analysis” provides in-depth information on Hoya Corporation’s market position in the different medical equipment markets it operates in. The report provides Hoya Corporation. market share information in seventeen key market categories – Intraocular Lens (IOL), Vision Care and Flexible Endoscopes. …
  • Dejour Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- 2012
    Dejour Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Dejour Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
  • グローバル茶(緑茶、紅茶)市場(~2019)
    The industry report Global Tea Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for tea in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, anal …
  • 再発髄芽細胞腫:グローバル臨床試験レビュー(2014年上半期)
    Recurrent Medulloblastoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Medulloblastoma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent Medulloblastoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Recurrent Medulloblastoma. It includes an overview of the trial …
  • エンタープライズアプリケーションSIの世界市場2015-2019
    About Global Enterprise Application System Integration Businesses worldwide depend on technology and integration solutions to sustain smooth business operations and drive revenue growth. Innovative IT applications and integrated solutions have enriched businesses functions. Enterprise application system integration has become a key enabler for streamlining business functions. Going forward, this t …
  • 世界の熱可塑性エラストマー市場
    A thermoplastic material softens, shows plastic property, when heated, but it does not set or get cured. Thermoplastics generally available in the form of pellets become softer and liquid when exposed to high temperature. Due to this property, molding and processing of thermoplastics becomes easy. Shape change of a thermoplastic material is completely physical and with the reapplication of heat, i …
  • WestFire Energy, Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    WestFire Energy, Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary WestFire Energy, Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
  • Mobile Handsets and Applications November 2010
    The Mind Commerce Mobile Handsets and Application report focuses on recent news and events in the Mobile Handset market. The Newsletter brings you stories on the major players and devices in the Cellular Handset industry. We will monitor the trends in the Smartphone market; examine new technology trends and their impact on the marketplace. We study and comment on press announcements from Apple, An …
  • 建設機械の世界市場予測(~2021)
    The construction equipment market is projected to grow at a CAGR of 4.11% during the forecast period, to reach a market size of USD 116.20 Billion by 2021, while the mining equipment market is projected to grow at a CAGR of 6.42%, to reach USD 136.03 Billion by 2021. A wide array of upcoming infrastructural projects and the rising demand for commodities has led to an increase in construction and m …
  • 抗菌テキスタイルの世界市場:作用物質別(合成有機化合物、金属・金属塩、バイオベース)、仕上げ技術別(排気、パッド・ドライ・キュア、吹き付け、発泡成形)、用途別(商業用、アパレル用、医療用、家庭用、その他)、地域別予測
    Global Antimicrobial Textiles Market to reach USD 946.0 million by 2025. Global Antimicrobial Textiles Market valued approximately USD 504.7 million in 2016 is anticipated to grow with a healthy growth rate of more than 7.23 % over the forecast period 2017-2025. Increasing demand for high-performance and microbe resistant fabrics for an increasing number of application areas and technological deve …
  • レゾルシノール・ジメチルエーテルの世界市場
    Resorcinol Dimethyl Ether (CAS 151-10-0) Market Research Report 2013 presents comprehensive data on resorcinol dimethyl ether markets globally and regionally (Europe, Asia, North America etc.) The Resorcinol Dimethyl Ether (CAS 151-10-0) Market Research Report 2013 includes resorcinol dimethyl ether description, covers its application areas and related patterns. It overviews resorcinol dimethyl et …
  • デジタルパソロジーの世界市場予測(~2022年):スキャナー、ソフトウェア、通信システム
    The global digital pathology market is projected to reach USD 756.1 Million by 2022 from USD 423.1 Million in 2017, at a CAGR of 12.3%. The key factors propelling the growth of this market include increasing initiatives by governments and industry players, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and growing applications …
  • Respiratory Insufficiency:グローバル臨床試験レビューH2, 2013
    Respiratory Insufficiency Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Respiratory Insufficiency Global Clinical Trials Review, H2, 2013" provides data on the Respiratory Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Respiratory Insufficiency. It includes an overview of the trial …
  • カミソリ及びカミソリ用刃市場(~2019):世界市場
    The expansion of the global razor and razor blade industry is forecast to reach 1.3% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 4.0%. Currently, razors account for 55.2% of the global demand while the remaining market share is divided between safety razor blades (40.2%) and parts of non-electric razors (4.6%). China, Germany, Japan, Poland …
  • タイプ2糖尿病:グローバル医薬品市場予測・分析(~2022)
    PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than doubling over this period. The main drivers of growth will be the …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。